DNA-triggered aggregation of copper, zinc superoxide dismutase in the presence of ascorbate

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Yin, Jun ^a   Hu, Si ^a   Jiang, Wei ^a   Liu, Liang ^a   Lan, Shemin ^a   Song, Xuegang ^a   Liu, Changlin ^a  

^a CENTRAL CHINA NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; COPPER ZINC SUPEROXIDE DISMUTASE; DNA; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA TEMPLATE; ENZYME METABOLISM; HUMAN; HYDROPHOBICITY; IN VITRO STUDY; MOLECULAR MECHANICS; NONHUMAN; OXIDATIVE STRESS; PROTEIN AGGREGATION; PROTEIN DNA BINDING; PROTEIN MODIFICATION; WILD TYPE; ANIMAL; CATTLE; CHEMISTRY; DRUG EFFECT; GENETICS; KINETICS; METABOLISM; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE;

ANIMALS; ASCORBIC ACID; BASE SEQUENCE; CATTLE; DNA; HUMANS; HYDROPHOBICITY; KINETICS; OXIDATION-REDUCTION; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; SUPEROXIDE DISMUTASE;

EID: 77957923726     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012328     Document Type: Article

References (70)

1. Fridovich I (1975) Superoxide dismutases. Annu Rev Biochem 44: 147-159.
2. Kinnula VL, Crapo J (2004) Superoxide dismutase in malihnant cells and human tumors. Free Radic Biol Med 36: 718-744.
3. Ezzi SA, Urashitani M, Julien J-P (2007) Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J Neurochem 102: 170-178.
4. Jaarsma D, Haasdijk ED, Grashorn JAC, Hawkins RW, Verspaget HW, et al. (2000) Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice cause mitochondrial vacuolization, axonal degradation, and premature motor neuron death and accelerates motor neuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol Dis 7: 623-643.
5. Gruzman A, Wood WL, Alpert E, Prasad MD, Miller RC, et al. (2007) Common molecular signature in SOD1 for both sporadic and familiar amytrophic lateral sclerosis. Proc Natl Acad Sci USA 104: 12524-12529.
6. Valentine JS, Hart PJ (2003) Misfolded CuZnSOD and amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 100: 3617-3622.
7. Valentine JS, Doucette PA, Potter SZ (2005) Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem 74: 563-593.
8. Bruijn LI, Miller TM, Cleveland DW (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27: 723-749.
9. Cleveland DW, Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2: 806-819.
10. Hart PJ (2006) Pathogenic superoxide dismutase structure, folding, aggregation and turnover. Curr Opin Chem Biol 10: 131-138.
11. Boillee S, Velde CV, Cleveland DW (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52: 39-59.
12. Shaw BF, Valentine JS (2007) How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein? Trends in Biochem Sci 32: 78-85.
13. Deng HX, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, et al. (1993) Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 261: 1047-1051.
14. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62.
15. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264: 1772-1775.
16. Julien J-P (2001) Amyotrophic lateral sclerosis: unfolding the toxicity of the misfolded. Cell 104: 581-591.
17. Gros-Louis F, Gaspar C, Rouleau GA (2006) Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochim Biophys Acta 1762: 956-972.
18. Simpson CL, Al-Chalabi A (2006) Amyotrophic lateral sclerosis as a complex genetic disease. Biochim Biophys Acta 1762: 973-985.
19. Bruijin LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, et al. (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281: 1851-1854.
20. Johnston JA, Dalton MJ, Gurney ME, Kopito RR (2000) Formation of high molecular weight complexes of mutant Cu,Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 97: 12571-12576.
21. Wang J, Xu G, Gonzales V, Coonfielld M, Fromholt D, et al. (2002) Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol Dis 10: 128-138.
22. Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, et al. (1997) ALSlinked SOD1 mutants G85R mediateds damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18: 327-338.
23. Liu J, Lillo C, Jonsson A, Velde CV, Ward CM, et al. (2004) Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 43: 5-17.
24. Zhang F, Zhu H (2006) Intracellular conformational alterations of mutant SOD1 and the implications for fALS-associated SOD1 mutant induced motor neuron cell death. Biochim Biophys Acta 1760: 404-414.
25. Chattopadhyay M, Valentine JS (2009) Aggregation of Copper-Zinc Superoxide Dismutase in Familial and Sporadic ALS. Antioxidants & Redox Signaling 11: 1603-1614.
26. Karch CM, Prudencio M, Winkler DD, Hart PJ, Borchelt DR (2009) Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proc Natl Acad Sci USA 106: 7774-7779.
27. Banci L, Bertini I, Boca M, Calderone V, Cantini F, et al. (2009) Structural and dynamic aspects related to oligomerization of apo SOD1 and its mutants. Proc Natl Acad Sci USA 106: 6980-6985.
28. Ferri A, Cozzolino M, Crosio C, Nencini M, Casciati A, et al. (2006) Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials. Proc Natl Acad Sci USA 103: 13860-13865.
29. Kawamata H, Manfredi G (2008) Different regulation of wild-type and mutant Cu,Zn superoxide dismutase localization in mammalian mitochondria. Hum Mol Genet 17: 3303-3317.
30. DiDonato M, Craig L, Huff ME, Thayer MM, Cardoso RMF, et al. (2003) ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization. J Mol Biol 332: 601-615.
31. Elam JS, Taylor AB, Strange R, Antonyuk S, Doucette PA, et al. (2003) Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat Struct Biol 10: 461-467.
32. Stathopulos PB, Rumfeldt JAO, Scholz GA, Irani RA, Frey HE, et al. (2003) Cu/Zn superoxide dismutase mutants associated with amytrophic lateral sclerosis show enhanced formation of aggregates in vitro. Proc Natl Acad Sci USA 100: 7021-7026.
33. Jiang W, Han Y, Zhou R, Zhang L, Liu C (2007) DNA is a template for accelerating the aggregation of Cu,Zn superoxide dismutase. Biochemistry 46: 5911-5923.
34. Kim Y-J, Nakatomi R, Akagi T, Hashikawa T, Takahashi R (2005) Unsaturated fatty acids induce cytotoxic aggregate formation of amyotrophic lateral sclerosislinked superoxide dismutase1 mutants. J Biol Chem 280: 21515-21521.
35. Calamai M, Kumita JR, Mifsud J, Parrini C, Ramazzotti M, et al. (2006) Nature and significance of the interactions between amyloid fibrils and biological polyelectrolytes. Biochemistry 45: 12806-12815.
36. Cherny D, Hoyer W, Subramaniam V, Jovin TM (2004) Double-stranded DNA stimulates the fibrillation of alpha-synuclein in vitro and is associated with the mature fibrils: an electron microscopy study, J Mol Biol 344: 929-938.
37. Valentine JS (2002) Do oxidatively modified proteins cause ALS? Free Radic Biol Med 33: 1314-1320.
38. Barber SC, Mead RJ, Shaw PJ (2006) Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta 1762: 1051-1067.
39. Kurahashi T, Miyazaki A, Suwan S, Isobe M (2001) Extensive investigations on oxidized amino acid residues in H2O2-treated Cu,Zn-SOD protein with LCESI- Q-TOF-MS, MS/MS for the determination of the copper-binding Site. J Am Chem Soc 123: 9268-9278.
40. Rakhit R, Lepock JR, Kondejewski LH, Cashman NR, Chakrabartty A (2004) Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J Biol Chem 279: 15499-15504.
41. Shaw BF, Lelie HL, Durazo A, Nersissian AM, Xu G, et al. (2008) Detergentinsoluble aggregates associated with amyotrophic lateral sclerosis in transgenic mice contain primarily full-length, unmodified superoxide dismutase-1. J Biol Chem 283: 8340-8350.
42. Rakhit R, Cunningham P, Furtos-Matei A, Dahan S, Qi XF, et al. (2002) Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J Biol Chem 277: 47551-47556.
43. Furukawa Y, O'Halloran TV (2005) Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo- and reduced form of SOD1, leading to unfolding and oxidative aggregation. J Biol Chem 280: 17266-17274.
44. Cozzolino M, Pesaresi MG, Amori I, Crosio C, Ferri A, et al. (2009) Oligomerization of mutant SOD1 in mitochondria of motoneuronal cells drives mitochondrial damage and cell toxicity. Antioxidants & Redox Signaling 11: 1547-1558.
45. Roberts BR, Tainer JA, Getzoff ED, Malencik DA, Anderson SR, et al. (2007) Structural Characterization of Zinc-deficient Human Superoxide Dismutase and Implications for ALS. J Mol Biol 373: 877-890.
46. Rice M (2000) Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci 23: 209-216.
47. Jiang W, Shen T, Han Y, Pan Q, Liu C (2006) Divalent-metal-dependent nucleolytic activity of Cu, Zn superoxide dismutase. J Biol Inorg Chem 11: 835-848.
48. Potter SZ, Valentine JS (2003) The perplexing role of copper-zinc superoxide dismutase in amyotrophic lateral sclerosis (Lou Gehrig's disease). J Biol Inorg Chem 8: 373-380.
49. Tiwari A, Xu Z, Hayward LJ (2005) Aberrantly increased hydrophobicity shared by mutants of Cu,Zn-superoxide dismutase in familial amyotrophic lateral sclerosis. J Biol Chem 280: 29771-29779.
50. Banci L, Bertini I, Boca M, Girotto S, Martinelli M, et al. (2008) SOD1 and amyotrophic lateral sclerosis: mutations and oligomerization. PLoS ONE 3: e1677.
51. Chattopadhyay M, Durazo A, Sohn SH, Strong CD, Gralla EB, et al. (2008) Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proc Natl Acad Sci USA 105: 18663-18668.
52. Chen Q, Espey MG, Sun AY, Lee J-H, Krishna MC, et al. (2007) Ascorbate in pharmacologic concentrations selectively ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci USA 104: 8749-8754.
53. Lee J-W, Helmann JD (2006) The PerR transcription factor senses H2O2 by metal-catalysed histidine oxidation. Nature 440: 363-367.
54. Niwa J-I, Yamada S-I, Ishigaki S, Sone J, Takahashi M, et al. (2007) Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1. J Biol Chem 282: 28087-28095.
55. Cozzolino M, Amori I, Pesaresi MG, Ferri A, Nencini M, et al. (2008) Cysteine 111 affects aggregation and cytotoxicity of mutant Cu,Zn-superoxide dismutase associated with familial amyotrophic lateral sclerosis. J Biol Chem 283: 866-874.
56. Karch CM, Borchelt DR (2008) A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis. J Biol Chem 283: 13528-13537.
57. Choi J, Rees HD, Weintraub ST, Levey AI, Chin LS, et al. (2005) Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with alzheimer and parkinson diseases. J Biol Chem 280: 11648-11655.
58. Fujiwara N, Nakano M, Kato S, Yoshihara D, Ookawara T, et al. (2007) Oxidative modification to cysteine sulfonic acid of cys111 in human copper-zinc superoxide dismutase. J Biol Chem 282: 35933-35944.
59. Jiang W, Zhang B, Yin J, Liu L, Wang L, et al. (2008) Polymorphism of the SOD1-DNA aggregation species can be modulated by DNA. Biopolymers 89: 1154-1179.
60. Durer ZAO, Cohlberg JA, Dinh P, Padua S, Ehrenclou K, et al. (2009) Loss of metal ions, disulfide reduction and mutations related to familial ALS promote formation of amyloid-like aggregates from superoxide dismutase. PLoS ONE 4: e5004.
61. Khare SD, Caplow M, Dokholyan NV (2004) The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 101: 15094-15099.
62. Bowling AC, Schulz JB, Brown RH, Jr., Beal MF (1993) Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 61: 2322-2325.
63. Ihara Y, Nobukuni K, Takata H, Hayabara T (2005) Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation. Neurol Res 27: 105-108.
64. Pardo CA, Xu Z, Borchelt DR, Price DL, Sisodia SS, et al. (1995) Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci USA 92: 954-958.
65. Barbosa LF, Cerqueira FM, Macedo AFA, Garcia CCM, Angeli JPF, et al. (2010) Increased SOD1 association with chromatin, DNA damage, p53 activation, and apoptosis in a cellular model of SOD1-linked ALS. Biochim Biophys Acta 1802: 462-471.
66. Chang Y, Kong Q, Shan X, Tian G, Ilieva H, et al. (2008) Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS. PLoS ONE 3: e2489.
67. Li X, Lu L, Bush DJ, Zhang X, Zheng L, et al. (2009) Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine/uridine-rich stability elements in the vascular endothelial growth factor 39-untranslated region. J Neurochem 108: 1032-1044.
68. Ogusucu R, Rettori D, Netto LES, Augusto O (2009) Superoxide dismutase 1- mediated production of ethanol- and DNA-derived radicals in yeasts challenged with hydrogen peroxide: molecular insights into the genome instability of peroxiredoxin-null strains. J Biol Chem 284: 5546-5556.
69. Ge WW, Wen W, Strong W, Lantz CL, Strong MJ (2005) Mutant copper-zinc superoxide dismutase binds to and destabilizes human low molecular weight neurofilament mRNA. J Biol Chem 280: 118-124.
70. Lippard SJ, Burger AB, Ugurbil K, Pantoliano MW, Valentine JS (1977) Nuclear magnetic resonance and chemical modification studies of bovine erythrocyte superoxide dismutase: evidence for zinc-promoted organization of the active site structure, Biochemistry 36: 1136-1141.